Commit To Purchase Enanta Pharmaceuticals At $37, Earn 16.4% Annualized Using Options
October 01, 2014 at 11:29 AM EDT
Investors eyeing a purchase of Enanta Pharmaceuticals, Inc. (ENTA) stock, but cautious about paying the going market price of $40.30/share, might benefit from considering selling puts among the alternative strategies at their disposal..